WASHINGTON — The U.S. Food and Drug Administration has approved a reformulated version of ranitidine, which was sold widely under the brand name Zantac, allowing the acid-reducing drug to return to ...
The FDA approved reformulated ranitidine tablets, marking the acid-reducing drug’s return to the U.S. market after a five-year absence. The updated formulation underwent safety testing and ...
The FDA has approved a reformulated version of ranitidine tablets that includes new storage conditions to address previous safety concerns regarding impurity formation. The Food and Drug ...
The Delaware Supreme Court ruled in favor of companies including GSK (NYSE:GSK), Pfizer (NYSE:PFE), and Boehringer Ingelheim on Thursday, rejecting the legitimacy of expert testimony that linked tens ...
Some Delaware Supreme Court justices signaled they may be skeptical of a bid by GSK Plc, Pfizer Inc. and other drugmakers to overturn a judge who allowed more than 80,000 lawsuits to proceed to trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback